Objective Assessment Machine Medicine offers Kelvin, a platform for objective motor assessment in Parkinson’s disease using computer vision and pose estimation. This presents a sales opportunity to medical institutions, research labs, and clinics seeking to improve measurement reproducibility and reduce rater drift in clinical studies and patient monitoring.

Remote Monitoring The platform works on any device such as smartphones or tablets, enabling scalable remote assessments. This can be pitched to telemedicine providers, home healthcare programs, and multi-site trials looking to minimize in-person visits while maintaining data quality.

Data-Driven Metrics Kelvin delivers objective metrics for tremor, bradykinesia, and other core symptoms from video data. There is a sales angle in offering standardized, auditable motor endpoints for clinical trials, regulatory submissions, and longitudinal patient tracking.

Growing Market Fit With 11-50 employees and revenue in the 1–10M range, Machine Medicine appears positioned for growth. Potential buyers include research hospitals, neurology clinics, and Parkinson’s disease consortia seeking scalable assessment tools and data analytics to enhance outcomes research.

Strategic Partners Their tech stack and emphasis on modern web-based tools suggest compatibility with academic collaborations and grant-funded studies. Opportunities exist to partner with universities, contract research organizations, and Parkinson’s registries to expand deployment and data collaboration.